Autopsy report · NCT03322813

ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma

“Study temporarily suspended until priorities are reassessed”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 years before it started.
• Suspended: paused, and may or may not restart.
• 15 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Na

Sponsor

InSightec

Sponsor type

Industry

Conditions

Glioma

Interventions

ExAblate 4000 - Type 2

Participants

15 (planned, not actual)

Sites

1

Countries

United States

Trials that died the same way

• Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients
  “Study suspended due to low accrual” (79% match in meaning)
• Prospective Study of Patients With Rheumatoid Arthritis After the Age of 65
  “Study suspended due to lack of PI to handle it” (76% match in meaning)
• Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients
  “Study Suspended. Slow enrollment.” (73% match in meaning)
• Norwegian Adenomyosis Study III: Peristalsis
  “Study was suspended due to organisational difficulties.” (73% match in meaning)
• Hair Cycle Modulation To Promote Human Wound Healing
  “Study suspended temporarily due to coronavirus pandemic.” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.